$2.70 -$0.10 (-3.6%)

11:51 AM EDT on 04/26/19

Nabriva Therapeutics (NASDAQ:NBRV)

CAPS Rating: 2 out of 5

Current Price $2.70 Mkt Cap $199.34
Open $2.82 P/E Ratio 0.00
Prev. Close $2.80 Div. (Yield) $0.00 (0.0%)
Daily Range $2.68 - $2.83 Volume 131,387
52-Wk Range $1.42 - $3.27 Avg. Daily Vol. 20

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

16 Outperform
1 Underperform
 

All-Star Players

3 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NBRV Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NBRV VS S&P 500 (SPY)

NASDAQ:NBRV Summary

Fools bullish on NASDAQ:NBRV are also bullish on:

Fools bearish on NASDAQ:NBRV are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NBRV.

Recs

0
Member Avatar OklaBoston (41.96) Submitted: 3/9/2019 5:55:18 PM : Outperform Start Price: $2.34 NASDAQ:NBRV Score: +10.79

Numerous senior officers have made open market purchases since the last open market sale years ago.

Recs

0
Member Avatar TMFTypeoh (92.28) Submitted: 10/23/2017 1:20:22 PM : Outperform Start Price: $6.10 NASDAQ:NBRV Score: -68.97

Next-generation antibiotics play. Approaching this as a basket.

Leaderboard

Find the members with the highest scoring picks in NBRV.

Score Leader

HDTVBG

HDTVBG (< 20) Score: +200.28

Highly dilutive secondary offering just turned all longs into bag holders. Hedge funds to the rescue ???

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
DavidSobel < 20 2/11/2019 Outperform 5Y $2.02 +35.64% +8.09% +27.55 0 Comment
slnoutperform < 20 3/6/2019 Outperform 5Y $2.18 +25.98% +5.47% +20.51 0 Comment
OklaBoston 41.96 3/11/2019 4/5/2019 Outperform 3Y $2.34 +17.09% +6.30% +10.79 1 Comment
zzlangerhans 99.79 3/18/2019 Underperform 1Y $2.88 -4.86% +3.92% +8.79 0 Comment
jeepdrew222 63.00 8/28/2018 Outperform 5Y $2.72 +0.74% +0.80% -0.06 0 Comment
karakartal < 20 10/4/2018 Outperform 5Y $3.05 -10.16% +0.49% -10.65 0 Comment
stainsolution < 20 12/20/2017 Outperform 5Y $5.67 -51.68% +9.07% -60.74 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MarkBiotech < 20 11/6/2017 Outperform 5Y $6.01 -54.41% +12.99% -67.40 0 Comment
efarev 98.69 10/24/2017 Outperform 5Y $6.04 -54.64% +14.03% -68.67 0 Comment
TMFTypeoh 92.28 10/23/2017 Outperform 5Y $6.10 -55.08% +13.88% -68.97 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NBRV.

Advertisement